JP2006513232A5 - - Google Patents

Download PDF

Info

Publication number
JP2006513232A5
JP2006513232A5 JP2004564537A JP2004564537A JP2006513232A5 JP 2006513232 A5 JP2006513232 A5 JP 2006513232A5 JP 2004564537 A JP2004564537 A JP 2004564537A JP 2004564537 A JP2004564537 A JP 2004564537A JP 2006513232 A5 JP2006513232 A5 JP 2006513232A5
Authority
JP
Japan
Prior art keywords
composition
prostaglandin
compound
dihydro
prostaglandin compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004564537A
Other languages
English (en)
Japanese (ja)
Other versions
JP4889219B2 (ja
JP2006513232A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2003/016857 external-priority patent/WO2004060377A1/en
Publication of JP2006513232A publication Critical patent/JP2006513232A/ja
Publication of JP2006513232A5 publication Critical patent/JP2006513232A5/ja
Application granted granted Critical
Publication of JP4889219B2 publication Critical patent/JP4889219B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2004564537A 2002-12-27 2003-12-26 腹部不快感の処置のためのプロスタグランジン誘導体 Expired - Lifetime JP4889219B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US43646202P 2002-12-27 2002-12-27
US43646302P 2002-12-27 2002-12-27
US60/436,462 2002-12-27
US60/436,463 2002-12-27
PCT/JP2003/016857 WO2004060377A1 (en) 2002-12-27 2003-12-26 Derivatives of prostaglandins for treating abdominal discomfort

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011240314A Division JP2012031202A (ja) 2002-12-27 2011-11-01 腹部不快感の処置のためのプロスタグランジン誘導体

Publications (3)

Publication Number Publication Date
JP2006513232A JP2006513232A (ja) 2006-04-20
JP2006513232A5 true JP2006513232A5 (enExample) 2007-02-15
JP4889219B2 JP4889219B2 (ja) 2012-03-07

Family

ID=32717850

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2004564537A Expired - Lifetime JP4889219B2 (ja) 2002-12-27 2003-12-26 腹部不快感の処置のためのプロスタグランジン誘導体
JP2011240314A Pending JP2012031202A (ja) 2002-12-27 2011-11-01 腹部不快感の処置のためのプロスタグランジン誘導体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011240314A Pending JP2012031202A (ja) 2002-12-27 2011-11-01 腹部不快感の処置のためのプロスタグランジン誘導体

Country Status (15)

Country Link
US (3) US7795312B2 (enExample)
EP (2) EP2281564A3 (enExample)
JP (2) JP4889219B2 (enExample)
KR (2) KR20120045051A (enExample)
CN (1) CN1753680B (enExample)
AR (1) AR042670A1 (enExample)
AU (1) AU2003292556B2 (enExample)
BR (1) BRPI0317740B8 (enExample)
CA (1) CA2510051C (enExample)
ES (1) ES2591252T3 (enExample)
MX (1) MXPA05006981A (enExample)
NO (1) NO335441B1 (enExample)
NZ (1) NZ541110A (enExample)
TW (1) TWI336254B (enExample)
WO (1) WO2004060377A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI331920B (en) 2001-11-14 2010-10-21 Sucampo Ag Unit dosage form for relieving or treating constipation in human patients
EP1562604B1 (en) * 2002-10-23 2012-01-04 Sucampo AG Prostaglandin compounds for the treatment of obesity
US8337891B2 (en) * 2003-07-03 2012-12-25 Sucampo Ag Enteric coated composition comprising prostaglandin analogs as chloride channel opener
TWI387454B (zh) 2004-09-02 2013-03-01 蘇坎波公司 治療胃腸道疾病之方法及組成物
US20060281818A1 (en) * 2005-03-21 2006-12-14 Sucampo Ag, North Carolina State University Method for treating mucosal disorders
CN101180096B (zh) * 2005-03-21 2015-04-22 苏坎波公司 用于治疗粘膜疾病的方法和组合物
EP1871380B1 (en) * 2005-04-12 2011-10-19 Sucampo AG Combined use of prostaglandin compound and proton pump inhibitor for the treatment of gastrointestinal disorders
US7868045B2 (en) 2006-09-06 2011-01-11 Sucampo Ag Method for promoting gastrointestinal bicarbonate secretion
JP2010519177A (ja) * 2007-02-27 2010-06-03 スキャンポ・アーゲー ミトコンドリアを保護するための組成物および方法
US20090012165A1 (en) 2007-07-03 2009-01-08 Sucampo Ag Pharmaceutical combination of nsaid and prostaglandin compound
US20090030072A1 (en) 2007-07-03 2009-01-29 Sucampo Ag Pharmaceutical combination of opioid and prostaglandin compound
JP5797655B2 (ja) * 2009-09-18 2015-10-21 アドラー・コーポレーション 消化管障害のためのオピオイド受容体アンタゴニストの使用
IT1402047B1 (it) * 2010-10-19 2013-08-28 Cross Pharma Sa Uso del mexiprostil nel trattamento delle malattie infiammatorie intestinali
JO3363B1 (ar) 2011-04-13 2019-03-13 Epizyme Inc مركبات بنزين مستبدلة بأريل أو أريل غير متجانس
WO2013161973A1 (en) * 2012-04-23 2013-10-31 Sucampo Ag Method for treating irritable bowel syndrome with diarrhea
CN105102432B (zh) 2012-10-15 2019-01-04 Epizyme股份有限公司 经取代的苯化合物
WO2014159679A1 (en) 2013-03-12 2014-10-02 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Methods for using lubiprostone to absorb fluid from the subretinal space

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1581886A (en) * 1977-05-26 1980-12-31 May & Baker Ltd Prostanol derivatives
CA1322749C (en) 1987-01-28 1993-10-05 Ryuzo Ueno Prostaglandins of the d series, and tranquilizers and soporifics containing the same
US5166174A (en) 1987-01-28 1992-11-24 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti-ulcers containing same
US5221763A (en) 1987-04-30 1993-06-22 R-Tech Ueno, Ltd. Prostaglandins of the F series
JPH0681728B2 (ja) * 1987-10-02 1994-10-19 株式会社上野製薬応用研究所 下 剤
US5317032A (en) * 1987-10-02 1994-05-31 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Prostaglandin cathartic
JP2579193B2 (ja) 1988-07-19 1997-02-05 小野薬品工業株式会社 16,16−ジフルオロ−15−オキソ−15−デオキシpge誘導体
TW224942B (enExample) 1990-04-04 1994-06-11 Adka Ueno Kk
EP0455448B1 (en) * 1990-05-01 1998-12-09 R-Tech Ueno Ltd. Treatment of pancreatic disease with 15-keto-prostaglandin E compounds
CA2150287C (en) 1994-06-03 2004-08-10 Ryuji Ueno Agent for treating hepato-biliary diseases
US6242485B1 (en) 1996-06-10 2001-06-05 R-Tech Ueno Endothelin antagonist
US6046239A (en) * 1997-08-05 2000-04-04 American Home Products Corporation Anthranilic acid analogs
EP0978284B1 (en) * 1997-11-28 2008-07-23 Sucampo AG Use of 15-keto-prostaglandin-e compounds as endothelin antagonists
US6492417B1 (en) * 1997-12-22 2002-12-10 Alcon Manufacturing, Ltd. 11-deoxy-16-fluoro-PGF2α analogs as FP receptor antagonists
DE60039727D1 (de) * 1999-10-15 2008-09-11 Sucampo Ag Neue Zusammensetzung enthaltend eine bicyclische Verbindung und ein Glycerid
JP4183943B2 (ja) * 2000-04-06 2008-11-19 スキャンポ・アーゲー 15−ケトプロスタグランジンを含む胆汁分泌促進剤組成物
US6414016B1 (en) * 2000-09-05 2002-07-02 Sucampo, A.G. Anti-constipation composition
TWI302100B (en) * 2001-05-02 2008-10-21 Sucampo Ag Composition for treating drug-induced constipation
AR035242A1 (es) * 2001-05-18 2004-05-05 Sucampo Ag Uso de un lipido bioactivo halogenadopara preparar una composicion catartica y compuesto lipido bioactivo halogenado
AU2002330747B2 (en) 2001-08-31 2007-07-19 Sucampo Ag Prostaglandin analogs as chloride channel opener
TWI331920B (en) * 2001-11-14 2010-10-21 Sucampo Ag Unit dosage form for relieving or treating constipation in human patients
US7732487B2 (en) * 2001-11-19 2010-06-08 Sucampo Ag Method for treating a disease or condition responsive to opening of C1C-2 channel

Similar Documents

Publication Publication Date Title
CN1133434C (zh) 作为治疗剂的环戊烷庚烷(烯)酸、2-杂芳基链烯基衍生物
CN100335049C (zh) 泻药组合物
JP4044967B2 (ja) 11,15−o−ジアルキルプロスタグランジンe誘導体、それらの製造方法およびそれらを有効成分として含有する薬剤
KR100349964B1 (ko) ω-시클로알킬 프로스타글란딘 E1 유도체
JP3174563B2 (ja) 5−チア−ω−置換フェニル−プロスタグランジンE誘導体、それらの製造方法およびそれらを有効成分として含有する薬剤
DK2653468T3 (en) Bicyclic compound AND USE THEREOF FOR MEDICAL PURPOSES
JP2004527567A5 (enExample)
JPH10265454A (ja) 3,7−ジチアプロスタン酸誘導体、それらの製造方法およびそれらを有効成分として含有する薬剤
JPWO1998034916A1 (ja) 11,15−o−ジアルキルプロスタグランジンe誘導体、それらの製造方法およびそれらを有効成分として含有する薬剤
WO1998012175A1 (en) Fluorinated prostaglandin derivatives and medicines
JP2005511607A (ja) EP2受容体作動剤としてのω−シクロアルキル17−ヘテロアリールプロスタグランジンE2類似体
JP2004507521A5 (enExample)
JP6052175B2 (ja) 左室拡張機能改善剤
US7652063B2 (en) 10-hydroxy-11-dihydroprostaglandin analogs as selective EP4 agonists
JP2007512252A (ja) 緑内障および関連疾患を処置するための新規プロスタミド
JP2006506381A5 (enExample)
JP2004529960A5 (enExample)
WO1999027934A1 (fr) Antagoniste d'endotheline
CN1509176A (zh) 导泻组合物
CN101102989A (zh) 用于治疗高眼压的取代的环戊烷或环戊酮
JP2008528440A5 (enExample)
JP2007518685A5 (enExample)
JP2004519412A5 (enExample)
JP2004529177A5 (enExample)
JP2004538306A5 (enExample)